Electroencephalographic Study of the Mechanisms of Inhibition of Emotional Memories in Young Healthy Subjects (ENGRAMME)

Etude Par électroencéphalographie Des mécanismes d'Inhibition de Souvenirs émotionnels Chez le Sujet Jeune Sain

Forgetfulness has long been considered a pathology of memory. However, the brain's voluntary suppression of certain unpleasant memories is essential for building a healthy memory. This suppression capacity can be measured using the "Think/No-Think" (TNT) paradigm.However, while the areas involved in these processes of suppression are now well described, the nature and temporal dynamics of the processes of inhibition and orientation of attention is still poorly defined. The aim of this study is to describe the nature of the attentional and inhibitory mechanisms involved in the suppression of emotionally negative memories, and their temporal articulation using electroencephalography (EEG). To this end, we will use a model of memory deletion derived from a perceptual attentional task and simulating the deletion phase in order to control the nature and timing of the processes involved. This approach will allow us to observe the presence of correspondences between the responses measured during the attentional test simulating the suppression and the actual phase of suppression, for which we cannot control the nature of the operations undertaken by the subject. In addition, we will assess the emotional response through physiological measures of autonomic nervous system activity (heart rate and electrodermal response) immediately after the TNT phase or one day later, which will allow us to evaluate the influence of memory suppression mechanisms on their emotional content.

From a practical point of view, this study is organized into 3 groups of participants (healthy young adults). Each group will perform a perceptual attentional test and a TNT task, which will be preceded and followed by a measure of emotional response. Group 1 will allow us to test our main hypothesis from a behavioral point of view, as well as to calibrate the attentional task and its consistency with the TNT task. Group 2 will carry out the same tests but during an EEG examination to decode the temporal dynamics of attention states during the process of memory suppression. Group 3 will perform these same tests with a 24-hour interval between the TNT phase and the emotional assessment to estimate the effect of a retention period on forgetfulness functions.

The description of these mechanisms and their physiological correlates will allow us to better understand how this ability to voluntarily control the flow of thoughts associated with negative memories is implemented, and thus to better understand the alterations in this capacity that can be observed during certain mental pathologies such as anxiety or depression.

Study Overview

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 140330 Caen Cedex 9
        • Service de neurologie CHU de Caen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female aged between 18 and 35 years
  • Affiliated to a social security scheme
  • Having French as their mother tongue
  • Right-handed
  • High school graduate or equivalent
  • Having signed a written informed consent

Exclusion Criteria:

  • Pregnancy in progress, pregnancy test will be performed
  • Person deprived of liberty by judicial or administrative decision
  • Person hospitalized without consent and not subject to legal protection measures, and person admitted to a health or social care facility for purposes other than research
  • Minor
  • Adults subject to legal protection measure (guardianship, curatorship or judicial protection), adults unable to express their consent and not subject to protection measure
  • Person subject to an exclusion for another research
  • History of a neurological, psychiatric disorders, or head trauma with loss of consciousness for more than an hour
  • History of cancer over the last 5 years, with the exception of squamous cell carcinomas of the skin
  • Presence or history of chronic alcoholism or drug addiction
  • Taking medications that may alter cognitive and/or brain function (decision of the principal investigator)
  • Presence of visual and/or auditory disorders sufficiently significant to affect the progress of the tests
  • Contraindications to electroencephalography
  • Presentation of unpleasant images that are too emotionally disturbing for the participant (by decision of the physician)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: pretest healthy participants
Cognitive Assessments
measurement of the points of gaze
Electrophysiological monitoring method to record electrical activity of the brain
measurement of the electrical activity of the heart
Experimental: healthy participant 10 min delayed recall
10 min delayed recall
Cognitive Assessments
measurement of the points of gaze
Electrophysiological monitoring method to record electrical activity of the brain
measurement of the electrical activity of the heart
Experimental: healthy participant 24 h delayed recall
24 h delayed recall
Cognitive Assessments
measurement of the points of gaze
Electrophysiological monitoring method to record electrical activity of the brain
measurement of the electrical activity of the heart

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion psychopathological scales
Time Frame: Inclusion visit
Entered into a computer
Inclusion visit
Measurement of the electrodermal conductance
Time Frame: Day1
For emotional evaluation when presenting negative images
Day1
Measuremet of heart rate
Time Frame: Day 1
For emotional evaluation when presenting negative images
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attentional task
Time Frame: Day 1 and Day 2
This test is performed on a computer after learning pairs of images
Day 1 and Day 2
Test of "Think/No-Think"
Time Frame: Day1 and Day2
This test is performed on a computer after learning pairs of images
Day1 and Day2
Measurement of the electrodermal conductance
Time Frame: Day 1 and Day 2
For emotional evaluation after learning pairs of images
Day 1 and Day 2
Measuremet of heart rate
Time Frame: Day 1 and Day 2
For emotional evaluation after learning pairs of images
Day 1 and Day 2
Measurement of electroencephalographic activity
Time Frame: Day1 and Day 2
Subjects will be equiped with electrodes during the attentional task and " Think/No-Think " test
Day1 and Day 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2016

Primary Completion (Actual)

April 12, 2019

Study Completion (Actual)

April 12, 2019

Study Registration Dates

First Submitted

March 12, 2025

First Submitted That Met QC Criteria

March 17, 2025

First Posted (Actual)

March 24, 2025

Study Record Updates

Last Update Posted (Estimated)

September 3, 2025

Last Update Submitted That Met QC Criteria

September 1, 2025

Last Verified

March 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Cognitive Assessments

Subscribe